Analysis for TSN
- 📈 Growth — 22/30
- 💰 Profitability — 14/20
- 🏦 Financial Health — 16/20
- 💵 Valuation — 13/20
- ⚠️ Risk — 5/10
Summary:
📈 Growth & Financial Trajectory
Across the seven quarters from 2024 Q3 through 2026 Q3 Tyson's revenues are broadly flat-to-up, rising from about $13.35B to about $13.87B (≈+$0.52B). Net income starts around $196M, peaks near $364M in 2024 Q4, then fluctuates and ends at about $186M in 2026 Q3. The revenue trajectory supports modest growth; earnings show cyclicality driven by margin mix and cost dynamics.
💰 Margins & Cash Flow
Gross margins sit in the 6%–8% range, with gross profit near $1.0B–$1.1B on about $13.5B revenue each quarter. Operating margins are narrow, typically 2%–4%, dipping mid-period and modestly improving by 2026 Q3. Net cash flow from operating activities was positive in most quarters, with peaks near $774M in 2025 Q3 and $942M in 2026 Q3; financing and investing cash flows swing, yielding occasional negative total cash flow.
🛡️ Balance Sheet & Liquidity
Total assets run around $36–37B, with equity near $18–18.7B. Current assets exceed current liabilities, giving a healthy current ratio in the 1.4–2.0 range. Noncurrent liabilities sit around $12–13B, supporting a solid balance sheet and resilience.
⚠️ Key Drivers & Risks
- Drivers: protein demand and consumer spending; input-cost dynamics (feed/energy) affecting margins.
- Risks: commodity price volatility and cyclicality; margins and earnings are sensitive to volume and cost shifts.